NAYA Biosciences, Inc. Price & Performance (NAYA)

INVO Fertility, formerly NAYA Biosciences, is set to begin trading under the new ticker 'IVF' on April 28. The move follows a corporate split, with the company focusing exclusively on fertility services and divesting most of its oncology business. The change aligns with recent U.S. policy efforts to expand IVF access.123

INVO Fertility will separate its fertility and oncology divisions, retaining only a minority position in NAYA Therapeutics. The fertility company will concentrate on expanding its network of clinics and distributing its INVOcell device, aiming to capitalize on the growing U.S. fertility market and recent regulatory support for IVF.425

INVO Fertility's restructuring, which includes a name change, new ticker, and strategic split, is designed to sharpen operational focus and boost shareholder value. However, the company faces execution risks, including delayed financial filings and the complexity of managing two distinct entities during the transition.564